On the same day last week that the Centers for Medicare and Medicaid Services rolled out plans to ease the flow of health ...

CMS launches digital health tech system with major tech firms; privacy advocates warn of risks to patient data as tools roll ...

England's National Health Service banned the use of puberty blockers for children seeking treatment for gender dysphoria, citing limited research. Puberty blockers, or gonadotropin-releasing ...

England’s National Health Service (NHS) has stopped prescribing puberty blockers for children and young people with gender dysphoria or gender incongruence, saying there is “not enough ...

Topline Puberty blockers will no longer be prescribed to minors under age 18 in England outside of regulated clinical trials, the country’s National Health Service announced Tuesday, following ...

Andrew Testa for The New York Times Health care spending rose by an average of less than 2 percent a year from 2010 to 2019, compared with 5.1 percent from 1998 to 2008.

The National Health Service said Friday that “outside of a research setting, puberty-suppressing hormones should not be routinely commissioned for children and adolescents.” ...

Crossing Healthcare is joining community health centers nationwide in celebrating National Health Center Week.